Randomised controlled trial of nocturnal insulin glargine versus human insulatard in combination with metformin in patients with type two diabetes currently treated with metformin/insulatard combination therapy

ISRCTN ISRCTN76123473
DOI https://doi.org/10.1186/ISRCTN76123473
Secondary identifying numbers N0237101842
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
30/09/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Niall Furlong
Scientific

Research Fellow
Diabetes Centre
Whiston Hospital
Prescot, Merseyside
L35 5DR
United Kingdom

Phone +44 (0)151 426 1600

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study objectivesThe aim of the present open-labelled, randomised controlled study is to examine effectiveness of insulin glargine in combination with metformin 1 g twice daily (bid) - 1 g three times a day (tds) compared with insulatard combined with metformin (same dose) in type two diabetic patients currently treated with insulatard/metformin combination therapy.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedDiabetes
InterventionRandomised controlled trial. Patients randomised to:
1. Nocturnal insulin glargine
2. Human insulatard in combination with metformin
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Glargine, metformin, insulatard
Primary outcome measure1. Glycosylated haemoglobin (HbA1c)
2. Tasting blood glucose
3. Frequency of hypoglycaemia
4. Weight change
Secondary outcome measuresWell being and diabetes treatment satisfaction measured using appropriate validated questionnaires.
Overall study start date01/08/2001
Completion date31/07/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants80
Key inclusion criteria80 patients.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/08/2001
Date of final enrolment31/07/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Research Fellow
Prescot, Merseyside
L35 5DR
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Government

St Helens and Knowsley Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan